Accu-Chek Solo micropump system with interoperable technology

FDA 510(k) K213134 · Roche Diabetes Care GmbH

Substantially Equivalent

510(k) numberK213134

Submission

Device name
Accu-Chek Solo micropump system with interoperable technology
Applicant
Roche Diabetes Care GmbH
Mannheim, DE
Received
September 27, 2021
Decision date
August 10, 2023
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QFG – Alternate Controller Enabled Insulin Infusion Pump
Device class
Class II (moderate risk)
Regulation
21 CFR 880.5730
Specialty
Clinical Chemistry

An alternate controller enabled insulin infusion pump (ACE insulin pump) is a device intended for the infusion of insulin into a patient. The ACE insulin pump may include basal and bolus drug delivery at set or variable rates. ACE insulin pumps are designed to reliably and securely communicate with external devices, such as automated insulin dosing systems, to allow insulin delivery commands to…

Other 510(k)s with product code QFG

510(k)DeviceApplicantDecision
K260001Mint ACE PumpQFG · Traditional Beta Bionics, Inc.09/11/2026SE
K261672twiist Automated Insulin Delivery (AID) SystemQFG · Special Deka Research and Development06/17/2026SE
K253976iLet ACE PumpQFG · Traditional Beta Bionics, Inc.04/30/2026SE
K253743MiniMed Flex pumpQFG · Traditional Medtronic Minimed, Inc.03/12/2026SE
K253470MiniMed 780G Insulin Pump (MMT-1884); MiniMed 780G Insulin Pump Kit (MMT-1894)QFG · Traditional Medtronic Minimed, Inc.01/15/2026SE
K253074Tandem Mobi insulin pump with interoperable technologyQFG · Traditional Tandem Diabetes Care, Inc.11/06/2025SE
K252770iLet ACE PumpQFG · Special Beta Bionics, Inc.09/29/2025SE
K250792t:slim X2 insulin pump with interoperable technologyQFG · Traditional Tandem Diabetes Care, Inc.09/24/2025SE
K251032MiniMed 780G insulin pumpQFG · Traditional Medtronic Minimed, Inc.07/01/2025SE
K250930twiist systemQFG · Special Deka Research & Development Corp.04/02/2025SE

More from Deka Research & Development Corp.

510(k)DeviceDecision
K232509Accu-Chek Safe-T-Pro Uno Lancing DeviceFMK · Traditional 11/13/2023SE
K232488Accu-Chek Safe-T-Pro Plus Lancing DeviceFMK · Traditional 11/13/2023SE
K213131Accu-Chek Guide Solo diabetes manager blood glucose monitoring systemNBW · Traditional 08/10/2023SE
K220849Accu-Chek Safe-T-Pro Plus Lancing DeviceFMK · Traditional 05/19/2022SE
K203711IWL2020 Blood Glucose Monitoring SystemNBW · Traditional 05/06/2022SE
K220608Accu-Chek FastClix Blood Lancing SystemQRL · Traditional 04/29/2022SE
K220364Accu-Chek Safe-T-Pro Uno Lancing DeviceFMK · Traditional 04/05/2022SE
K214022Accu-Chek Softclix Blood Lancing SystemQRL · Traditional 02/17/2022SE
K181131Accu-Chek Guide Me Blood Glucose Monitoring SystemNBW · Special 12/13/2018SE
K160944ACCU-CHEK Guide Blood Glucose Monitoring SystemNBW · Traditional 08/31/2016SE

Questions and answers

When was Accu-Chek Solo micropump system with interoperable technology cleared by the FDA?

Accu-Chek Solo micropump system with interoperable technology (K213134) received a 510(k) decision of Substantially Equivalent on August 10, 2023, 682 days after the submission was received.

What is the product code of K213134?

The FDA product code is QFG – Alternate Controller Enabled Insulin Infusion Pump, a Class II (moderate risk) device regulated under 21 CFR 880.5730.